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Abstract
Background: People with dementia admitted to the acute hospital often receive poor quality care particularly with
regards to management of behavioural and psychiatric symptoms of dementia (BPSD) and of pain. There have
been no UK studies on the prevalence and type of pain or BPSD in people with dementia in this setting, or on
how these may impact on patients, carers, staff and costs of care.
Methods/Design: We shall recruit older people with dementia who have unplanned acute medical admissions
and measure the prevalence of BPSD using the Behave-AD (Behaviour in Alzheimer’s Disease) and the CMAI
(Cohen Mansfield Agitation Inventory). Pain prevalence and severity will be assessed by the PAINAD (Pain
Assessment in Advanced Dementia) and the FACES pain scale. We will then analyse how these impact on a variety
of outcomes and test the hypothesis that poor management of pain is associated with worsening of BPSD.
Discussion: By demonstrating the costs of BPSD to individuals with dementia and the health service this study will
provide important evidence to drive improvements in care. We can then develop effective training for acute
hospital staff and alternative treatment strategies for BPSD in this setting.
Background
Dementia is common in older people admitted to acute
hospitals in the United Kingdom (UK), affecting 42% of
adults over 65 years with an unplanned medical admis-
sion. These patients have high mortality with a quarter
of those with severe impairment dying during the index
hospital admission [1]. Dementia significantly increases
the length of hospital admission [2-5], complications [4]
and the risk of iatrogenic harm through polypharmacy
[6]. A number of recent documents including the Eng-
lish National Dementia Strategy, the National Dementia
Research Summit and Alzheimer’sS o c i e t y“Counting
the Cost” report have raised concerns regarding the
quality of care received by people with dementia in
acute hospitals and have highlighted lack of original
research in this field [7-9].
Behavioural and psychological symptoms of dementia in
the acute hospital
The term “behavioural and psychological symptoms of
dementia” (BPSD) encompasses a range of symptoms
including agitation, aggression, delusions, hallucinations,
depression and apathy. These are common in dementia,
multifactorial in origin and often secondary to complex
interactions between the severity of dementia, the envir-
onment and other illness [10]. BPSD are extremely dis-
tressing for the patient and difficult to manage in the
busy acute hospital. They may lead to the inappropriate
use of antipsychotic drugs, increasing the risk of stroke,
falls and death [11].
Carers have given rich reports on how BPSD may
worsen during hospital admission[9]. However, although
there is some qualitative research, [12] in our recent sys-
tematic review [13], we found no studies on the type,
severity or frequency of BPSD in the acute hospital, how
hospital staff manage these symptoms and the impact
on patients. These data are vital if we are to develop
and evaluate effective non-pharmacological interventions
for BPSD in the acute hospital.
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Pain is commonly under detected and undertreated in
people with dementia [14,15]. Many clinical staff believe
that people with dementia actually experience less pain
[16]. This may occur because people with dementia are
unable to express clearly that they are in pain. Under-
treatment of pain may lead to protective responses such
as aggression, distress and agitation, vocalisations or
depression and withdrawal [17]. It may increase the risk
of delirium [18], slowing recovery and increasing func-
tional decline [16]. In acute hospitals in the UK it is not
usual clinical practice to assess routinely whether people
with dementia are in pain. However, this may be a
worthwhile approach as when pain assessment scales are
used in dementia patients the use of analgesics increases
significantly [19].
The relationship between BPSD and pain
Behavioural problems in people with dementia may be
an expression of unmet needs such as boredom, fear,
discomfort or pain [20]. However, the relationship
between BPSD and pain is poorly understood. The per-
ception and communication of pain is a complex pro-
cess and particular behaviours are not exclusively
associated with pain. In people with dementia such
behaviours may also indicate embarrassment, depression
or distress. “Pain behaviours” therefore lack specificity
and some “pain scales” may actually be detecting
broader distress. To understand any direction of causal-
ity, it is important to use self-report and observational/
behavioural pain scales concurrently [14]. More work is
required to establish whether the use of pain tools is
feasible in the acute hospital, whether these tools are
reliable in detecting pain and whether there is a rela-
tionship between pain, particularly that which is unde-
tected and undertreated, and BPSD.
Methods/Design
Aims
Our aim is to examine the impact of behavioural and
psychological symptoms (BPSD) and pain, during an
acute hospital admission, in people with dementia. We
shall explore two specific area s .F i r s t ,h o wb e h a v i o u r a l
and psychological symptoms (BPSD) affect outcomes for
the person with dementia, informal carers and the hos-
pital, and second the detection and management of pain
in people with dementia.
Objectives
Our main objectives are to examine, in older people
with dementia admitted to acute hospital wards:
￿ the prevalence and types of BPSD
￿ how hospital staff respond to and manage these
symptoms
￿ the impact of BPSD on costs of care
￿ the impact of BPSD on the person with dementia,
for example the prescription of antipsychotic drugs,
the length of hospital stay, quality of care and the
risk of adverse events
￿ prevalence of pain and how well this is detected
and managed by hospital staff
￿ the time spent by informal carers assisting nursing
staff with basic care tasks
Finally, we shall test the hypothesis that there is an
association between BPSD and pain, particularly
whether BPSD are a manifestation of under-detected or
under-treated pain.
Methods
This protocol describes an observational cohort study.
Setting
To ensure our population is representative we will
recruit from two London hospitals. Both cover a large
area of London encompassing socioeconomic and ethnic
diversity, serving a population of two million people, six
primary care trusts and four mental health trusts. The
hospitals have differing strengths and weaknesses in
terms of their Care Quality Commission ratings and are
at different stages of implementing the English National
Dementia Strategy with varying provision of liaison
psychiatry.
Sample size
We were unable to find studies in this setting on which
to base our power calculation. We therefore used data
from a community study of pain in people with dementia
that used the Cohen Mansfield Agitation Inventory
(CMAI) [21]. To analyse the hypothesised association
between pain and BPSD we will use repeated measures
(every 4 ± 1 days). Power depends on the correlation
between measurements which we are unable to predict.
We calculated a conservative estimate by considering a
perfect correlation between repeated measurements (r =
1). Shega et al. [22] reported a mean CMAI score of 50.5
and 42.5 in patients with and without pain respectively
(standard deviation 18.9). Assuming the presence of pain
in 55% of our sample [21], the power to detect a signifi-
cant difference with 250 patients would be 91%. To
ensure an adequate sample size for our other analyses we
have taken a point prevalence of BPSD of 31% from a
community based sample of people with dementia [10].
We will need to recruit 250 patients (125 from each hos-
pital) to ensure a 95% confidence interval for prevalence
estimates of BPSD with an acceptable 6% precision.
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In both hospitals, all patients are admitted to the medical
acute admissions unit (MAAU), before transfer to the
care of the elderly wards. Two research assistants will
spend four months at each site and see all patients
admitted to each MAAU who are under the care of the
geriatricians within 72 hours of admission. The geriatri-
cians will provide a list of people who have been admitted
under their care over the previous 24 hours. Research
assistants will ask ward nursing staff to identify patients
from this list who fit the inclusion criteria, see Figure 1.
Inclusion criteria
￿ patients over the age of 70 who have an unplanned
acute medical admission
￿ able to give verbal consent or an informal carer or
“professional consultee” available to give assent
￿ sufficient English language to complete the study
ratings
￿ Abbreviated Mental Test Score (AMTS [23]) of ≤
7/10 (routinely measured on admission)
Exclusion criteria
￿ patients who indicate either verbally or non-verb-
ally that they do not wish to participate
￿ patients consistently rated as being delirious during
the study without a previous diagnosis of dementia
￿ patients who are moribund, in a coma, non-English
speaking (the assessment tools selected for this study
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Figure 1 Participant recruitment and consent procedure.
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other than English) or where there are clinical con-
cerns that may preclude them being approached
Screening
All potential participants will be screened for delirium
using the Confusion Assessment Method (CAM) [24],
(Table 1). Those who are not delirious will be consented
to the study and have a MMSE assessment. If their
score is ≤ 24 they will be entered into the study.
Patients with delirium will be screened again 48 hours
later, if this has resolved they will undergo testing with
the MMSE. If they remain persistently delirious they
will not be eligible to participate as we will be unable to
establish whether or not they have an underlying
dementia. Patients with delirium but who have a clearly
documented previous diagnosis of dementia in the hos-
pital notes will enter the study.
If we were to exclude dementia patients with delirium
we would risk excluding those patients who are most
likely to have the greatest symptom burden and the
study would not be truly representative of patients
admitted to acute hospital wards in the UK.
Consent
Many patients will be acutely ill. They will have a
dementia, delirium or both and will not be able to give
fully informed consent. Therefore our consent proce-
dure has been developed to comply with capacity legis-
lation governing England and Wales (Mental Capacity
Act 2005). Our study was approved by the ethics com-
mittee of Central London REC3 which is “flagged” to
consider research on those unable to consent for
themselves. This is an observational study and the risk
of harm to the patient is negligible.
1. If a patient agrees to participate we will conduct a
brief, structured assessment of their capacity to con-
sent. If they have capacity to consent we will obtain
written informed consent from them.
2. If they do not have capacity to consent we will
attempt to identify their next of kin, carer or some-
one close to the person to give proxy assent. If we
cannot contact a next of kin within 48 hours of
initial screening we will contact a professional con-
sultee for assent (professional consultees will be
defined as a senior member of the clinical care team
who is not directly involved in the research or
patient’s care).
Study procedures
Study measures after consent
Dementia diagnosis will be confirmed using the opera-
tionalised DSM-1V criteria and dementia severity mea-
sured using the Functional Assessment Staging Scale
(FAST) [25]. The reason for admission, co-morbidities,
medication (cholinesterase inhibitors, analgesia and neu-
roleptics) and demographics (i.e. place of residence) will
be obtained from medical notes. Patients will undergo
observational assessment for BPSD (Behave-AD and
Cohen-Mansfield Agitation Inventory-CMAI[26,27]).
Pain will be assessed using a combination of methods
concurrently. The Pain Assessment in Advanced
Table 1 Study Assessment Tools
Confusion Assessment Measure (CAM)
[24]
Has a sensitivity of over 94% and specificity over 90% for detecting delirium. Distinguishes accurately
between delirium and dementia.
Abbreviated Mental Test Score
(AMTS) [23]
Global cognitive assessment tool recommended for screening patients admitted to hospital. Maximum
score of 10 cut off ≤7.
Mini-Mental State Examination
(MMSE) [33]
Most widely used screening test for cognitive impairment. Maximum score of 30 cut off ≤24.
Functional Assessment Staging Scale
(FAST) [25]
Describes a continuum of 7 successive stages of functional impairment, from normality to the most
severe dementia.
Charlson Co-Morbidity Index (CCI)[34] Calculates severity of chronic co-morbidity. Includes 19 diseases weighted on the basis of their
association with mortality, allowing for the documentation of painful co-morbidities
43
Behave-AD [26] Covers 7 domains of BPSD including delusions, hallucinations, affective disturbance and aggressiveness.
Includes a global rating of the trouble these behaviours cause to caregivers.
Cohen Mansfield Agitation Inventory
(CMAI) [27]
This rates a range of behaviours many of which are relevant and challenging on hospital wards, for
example wandering, grabbing on to people and pushing. It enables measurements over short timescales.
Pain Assessment in Advanced
Dementia (PAINAD) [28]
Validated observational pain tool that measures pain during care tasks and at rest.
Faces Pain Scale [29] Self report pain scale consisting of line drawings of 6 faces indicating increasing amounts of pain. Can be
used by people with advanced dementia.
Assessing Care of Vulnerable Elders
(ACOVE) [31]
Validated indicators of the quality of hospital care received by vulnerable older people. Designed to be
gathered from hospital notes post patient discharge.
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scale [28] will be used to assess pain at rest and during
a care task activity, followed by the self-reporting assess-
ments, the question “Do you have pain at this moment"?
and the Faces pain scale [29] (see Table 2). Pain and
BPSD measures will be obtained independently by sepa-
rate researchers.
Subsequent study assessments
Patients will be reviewed every 4 ( ± 1 days) and the
assessment for BPSD and pain repeated. Notes will be
reviewed and discussions held with the patient’sk e y
nurse to identify any possible cause for pain, e.g. consti-
pation or injury, adverse incidents, the context and pre-
cipitants for any BPSD e.g. during personal care tasks
and how staff dealt with any BPSD (for example with
sedatives) or managed pain (i.e. analgesia prescribed).
We will calculate the inter-rater reliability for the pain
and BPSD tools at regular intervals during the study.
On discharge from hospital
Data will be collected from notes and will include
adverse events, measured using validated pre-defined
criteria[30], falls, length of stay, whether antipsychotic
or pain medication was prescribed on discharge, and
whether there was a change of residence after discharge.
The ACOVE (Assessing Care of Vulnerable Elders) tool
will be used to assess quality of care. This examines 16
specific quality indicators in general hospital care and
geriatric-prevalent conditions (e.g., dementia, delirium,
pressure ulcers) and allows the calculation of adherence
rates for care processes (screening, diagnosis and treat-
ment) [31].
Table 2 Study Assessment Schedule
Measures Source Baseline Follow-up 4 ± 1 days Discharge Death
Confusion Assessment Method (CAM) 1,2,3,4 *
Abbreviated mental test score (AMTS) 3 *
Mini mental state examination (MMSE) 1 *
DSM1V dementia criteria 1,2,3,4 *
Functional Assessment Staging Scale (FAST) 1,2,3,4 *
Charlson co-morbidity index 4 *
Demographics 4 *
Reason for admission 4 *
Place of residence 4 * *
Waterlow score 4 * *
Pressure ulcers & grade 4 * * *
Use of parenteral feeding 4 * * *
Continence 4 * * *
Behave-AD 1,2,3,4 * *
Cohen Mansfield Agitation Inventory (CMAI) 1,2,3,4 * *
BPSD precipitants 1,2,3,4 * * * *
BPSD Non-pharmacological management 3,4 * * * *
BPSD medication 4 * * * *
Dementia medication 4 * * * *
Pain Assessment in Advanced Dementia (PAINAD) 1 * *
“Are you in pain” yes/no pain question 1 * *
Faces pain scale 1 * *
Possible precipitants for pain 1,2,3,4 * * * *
Analgesics prescribed 4 * * * *
Adverse events 4 * *
Length of admission 4 * *
Assessing Care of Vulnerable Elders (ACOVE) 4 * *
Carers questionnaire 2 * *
Economic Data 4 * *
1-Patient, 2-carer if present, 3-health professionals, 4-patient care records
BPSD- behavioural and psychological symptoms of dementia
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When the person with dementia has been discharged
from hospital, we will send a brief questionnaire to the
identified carer or next of kin asking questions about
their experiences of visiting their relative whilst in hos-
pital. We will clearly state that this will be anonymised
and will not be directly fed back to the clinical team.
We will not collect any personal data on the carers. The
ethics committee agreed that we will not ask them to
give signed consent; we will assume that if they have
completed the questionnaire and return it to us, they
have consented to participate.
General principles of data analysis
We shall use simple descriptive statistics for the demo-
graphic features of the cohort using Chi squared, t-tests
or non-parametric statistics if indicated. For prevalence
estimates of BPSD we will conduct a sensitivity analysis,
excluding patients whose BPSD appeared only in the
context of delirium. For some analyses we will create
overall “indicator” variables i.e. one to denote presence
of any BPSD at any time during the admission. Out-
comes will be divided into clinically relevant sub group-
ings i.e. falls, use of medications (antipsychotics,
sedatives) or prolonged length of stay above the median.
We shall use logistic regression to analyse the relation-
ship between our principle exposures, i.e. BPSD and
outcomes such as falls, controlling for potential con-
founders identified through clinical experience and
bivariate analyses. Appropriate corrections will be made
for multiple comparisons. For the analysis of the overall
relationship between pain and BPSD we will use Gener-
alised estimating equations (GEE) as we are using multi-
ple observations on the same individual and analyses are
clustered by participant. GEE is advantageous for use in
the context of this project as it does not require a
“balanced” design i.e. observations on all occasions on
each individual.
Health economics
We shall compare the average cost of care per hospital
admission for patients with and without BPSD. The ana-
lysis of hospital costs will include all costs incurred dur-
ing the admission, such as hotel costs, nursing, specialist
consultations, investigation s ,s u r g e r y ,a n da d d i t i o n a l
agency staff.
Unit costs will be obtained from the hospital finance
department, and applied to estimates of resource use.
These may vary in between the hospitals, which may
result in different average costs per admission.
Staff training
We recruited two research associates, ensuring that they
had experience of working with people with dementia
and in the busy acute hospital environment. They were
trained by ES and SS over a period of two weeks. This
included in-depth discussion and practice on all of the
study assessment tools, data collection and the process
of assessing mental capacity and obtaining consent for
people who do not have capacity, approaching carers
and the use of professional consultees according to the
MCA (2005).
Pilot study
The pilot study took place over a period of two weeks
and assessed the following: the identification and screen-
ing of patients, the consent process (including proce-
dures for informal carers and professional consultees to
give assent), practice and use of selected assessment
tools and the collection of data from varying sources.
This demonstrated that the study recruitment schedule
was both practical and feasible and that we were able to,
on average, recruit eight participants per week (the
number required to achieve an adequate sample size).
Discussion
When older people with dementia are admitted to hos-
pital with acute medical illness, it can be distressing for
them and their families. Symptoms such as pain may be
poorly detected and managed and often BPSD such as
agitation and aggression are exacerbated in this busy
environment. In turn disturbed behaviour in people
with dementia may be problematic for other patients
and health professionals. BPSD and pain may result in,
and be the result of, poor quality of care. There may
also be economic costs to the hospital. The need to con-
duct research in this field has recently been highlighted
by a number of government reports and strategies [32].
However, conducting clinical studies of people with
dementia in the acute hospital poses considerable chal-
lenges to researchers and this may explain why we
found little previous evidence of work in this setting
[13].
Challenges within the acute hospital environment
The acute hospital is an extremely busy environment in
which to conduct research, with patients being rapidly
assessed, transferred to MAAU and then moved to care
of the elderly wards, sometimes all within hours of
admission. This makes it difficult to track study partici-
pants and obtain accurate reports of their condition;
staff may not have had time to fully assess the patient’s
BPSD and continuity and consistency of information is
affected by staff shift changes. We have overcome many
o ft h e s ec h a l l e n g e sb yb u i l d ing good relationships with
doctors, nurses and allied health professionals on the
MAAU and care of the elderly wards. Before starting,
each unit and ward was provided with study information
folders and researchers met and discussed the study
with staff, answering questions or concerns. Researchers
work closely with ward clerks to identify where patients
have been transferred or discharged to.
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The development of this study gave us the opportunity
to explore ways in which we could recruit patients with
dementia who, by the nature of their illness, may not
have the mental capacity to give informed consent.
From the literature and personal communication with
other researchers in the field we were aware that gaining
ethical approval for similar studies has proved challen-
ging. We therefore explored and negotiated various
ways of obtaining consent (or proxy assent) within ethi-
cal guidelines whilst balancing the need to be able to do
research in this very difficult area. We followed advice
from the Mental Capacity Act (2005) Code of Practice i.
e. assessing the person with dementia using a structured
approach for testing capacity, seeking assent from a
carer when the person had lost capacity and using pro-
fessional consultees when a carer could not be con-
tacted. The pilot study demonstrated that this method
of obtaining consent was both practical and feasible
within the acute setting. Our methods may prove useful
to other researchers embarking on similar projects in
the future.
Challenges in supporting study staff
There is a high volume and rapid turnover of patients,
and research workers screen numerous patients to iden-
tify potential participants. This involves, the assessment
of capacity, contacting carers or professional consultees
to give assent within a short window of opportunity (72
hours of admission). The researchers may have a large
number of follow-up assessments to complete on a daily
basis.
In addition researchers may occasionally witness poor
quality care, for example, when pain or BPSD are not
managed appropriately by staff, and not be able to
directly and immediately intervene. This is not an inter-
vention study and there is the potential for a Hawthorne
effect around study participants. However, procedures
have been put in place for the reporting of perceived
sub-standard clinical care to the study supervisors who
then follow a standardised procedure to inform the
appropriate senior clinical staff. Supportive regular clini-
cal supervision is provided within the research team.
Importance of support from other agencies
The success of this study depends upon support from
senior staff in NHS trusts. This work may be perceived
as potentially critical to the clinical teams involved, but
they were willing for us to research the clinical care
delivered in their organisations. The Alzheimer’s Society
Quality Research Monitors (mainly former family carers
of people with dementia) are provided by our funding
organisation to help ensure that our study gains a
perspective from people with dementia and their carers.
Their advice has been vital in developing our proxy
assent procedures and they continue to actively partici-
pate in our study steering group meetings.
Final conclusions
We have overcome numerous challenges in the develop-
ment of this study, particularly in regard to consent pro-
cedures and the large number of potential study
participants who need to be screened. The study will
help to fill in many of the gaps we have identified in the
current literature regarding the effects of BPSD and
pain during acute hospital admission on older people
with dementia. Improved detection and treatment of
pain with adequate analgesia may be an effective strat-
egy for treating BPSD, without necessarily resorting to
antipsychotic medications.
A better understanding of these symptoms, their
impact and costs will drive more effective treatment
strategies and investment in services, to improve the
standard of hospital care and the quality of life for peo-
ple with dementia.
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